BRIEF published on 10/21/2026 at 17:50, 14 days 9 hours ago Median Technologies to Highlight AI Imaging at ESMO 2026 AI Technology Clinical Trials Oncology Imaging ESMO 2026 RANO 2.0
BRIEF published on 10/21/2026 at 17:50, 14 days 9 hours ago Median Technologies showcases its innovations at ESMO 2026 Artificial Intelligence Clinical Trials Medical Imaging ESMO Congress Neuro-oncology
PRESS RELEASE published on 10/21/2026 at 17:45, 14 days 9 hours ago Inside Information / Other news releases Median Technologies to showcase iCRO's central and AI-powered imaging services for oncology clinical trials at ESMO 2026. Learn about RANO 2.0 and emphysema prevalence in NSCLC patients Oncology Median Technologies ICRO ESMO 2026 RANO 2.0
BRIEF published on 10/20/2026 at 17:50, 15 days 9 hours ago Median Technologies at the 50th I-ELCAP Conference on Lung Cancer Screening AI Technology Median Technologies Lung Cancer Screening Eyonis® LCS I-ELCAP Conference
BRIEF published on 10/14/2026 at 17:50, 21 days 9 hours ago Eyonis Inc. unveils promising results from eyonis® LCS at CHEST 2026 FDA Artificial Intelligence Lung Cancer Screening Eyonis® LCS CHEST 2026
BRIEF published on 10/14/2026 at 17:50, 21 days 9 hours ago Eyonis Inc. to Showcase AI in Lung Cancer Detection at CHEST 2026 AI In Healthcare Lung Cancer Screening Eyonis® LCS CHEST 2026 FDA-Cleared Technology
PRESS RELEASE published on 10/14/2026 at 17:45, 21 days 9 hours ago Inside Information / Other news releases eyonis Inc. to present study results supporting eyonis® LCS performance claims at CHEST 2026. Key insights into AI/ML-based Software as a Medical Device for lung cancer screening. Importance of pulmonologists in adoption Eyonis® LCS CHEST 2026 Eyonis Inc. Pulmonologists AI-enabled Decision Support
BRIEF published on 09/15/2026 at 17:50, 1 month 19 days ago Median Technologies Secures Major €8.4 Million iCRO Project AI-powered Solutions Phase III Trial ICRO Project Oncology Imaging Global Pharmaceutical
PRESS RELEASE published on 09/15/2026 at 17:45, 1 month 19 days ago Inside Information / Other news releases Median Technologies secures an €8.4 million global phase III oncology imaging project, expanding its iCRO order backlog and revenue visibility. Project awarded by a leading European pharmaceutical company for brain cancer study Pharmaceutical Company Median Technologies Global Project ICRO Oncology Imaging
BRIEF published on 09/08/2026 at 19:50, 1 month 26 days ago Median Technologies: Information on voting rights and capital Share Capital Voting Rights Treasury Shares Financial Market Median Technologies
Published on 11/04/2026 at 23:10, 4 hours 15 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 4 hours 25 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 10 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 20 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:10, 14 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 3 hours 22 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 7 hours 43 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 7 hours 59 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 8 hours 41 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:00, 9 hours 24 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 17:44, 9 hours 41 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 15 hours 28 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
